Our top pick for
Realogy Holdings Corp is a real estate services business based in the US. Realogy shares (RLGY) are listed on the NYSE and all prices are listed in US Dollars. Realogy employs 9,235 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$19.28|
|52-week range||$9.45 - $21.03|
|50-day moving average||$18.34|
|200-day moving average||$17.61|
|Wall St. target price||$22.83|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$2.53|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-3.55%|
|1 month (2021-09-24)||4.90%|
|3 months (2021-07-23)||7.89%|
|6 months (2021-04-23)||26.10%|
|1 year (2020-10-23)||91.84%|
|2 years (2019-10-24)||118.35%|
|3 years (2018-10-24)||5.36%|
|5 years (2016-10-24)||24.71|
Valuing Realogy stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Realogy's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Realogy's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Realogy shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Realogy's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.37. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Realogy's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Realogy's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $862 million.
The EBITDA is a measure of a Realogy's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$7.6 billion|
|Operating margin TTM||8.73%|
|Gross profit TTM||$2.7 billion|
|Return on assets TTM||5.6%|
|Return on equity TTM||16.75%|
|Market capitalisation||$2.2 billion|
TTM: trailing 12 months
There are currently 13.7 million Realogy shares held short by investors – that's known as Realogy's "short interest". This figure is 11.2% up from 12.3 million last month.
There are a few different ways that this level of interest in shorting Realogy shares can be evaluated.
Realogy's "short interest ratio" (SIR) is the quantity of Realogy shares currently shorted divided by the average quantity of Realogy shares traded daily (recently around 1.5 million). Realogy's SIR currently stands at 9.39. In other words for every 100,000 Realogy shares traded daily on the market, roughly 9390 shares are currently held short.
However Realogy's short interest can also be evaluated against the total number of Realogy shares, or, against the total number of tradable Realogy shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Realogy's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Realogy shares in existence, roughly 120 shares are currently held short) or 0.1765% of the tradable shares (for every 100,000 tradable Realogy shares, roughly 177 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Realogy.
Find out more about how you can short Realogy stock.
We're not expecting Realogy to pay a dividend over the next 12 months.
Over the last 12 months, Realogy's shares have ranged in value from as little as $9.45 up to $21.03. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Realogy's is 2.6852. This would suggest that Realogy's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Realogy Holdings Corp. , through its subsidiaries, provides residential real estate services. It operates through three segments: Realogy Franchise Group, and Realogy Brokerage Group. The Realogy Franchise Group segment franchises its residential real estate brokerages under the Century 21, Coldwell Banker, Coldwell Banker Commercial, Corcoran, ERA, Sotheby's International Realty, and Better Homes and Gardens Real Estate brand names. This segment also offers lead generation and relocation services. As of December 31, 2020, this segment's real estate franchise systems and proprietary brands had approximately 20,100 offices and 320,700 independent sales agents worldwide. The Realogy Brokerage Group segment owns and operates a full-service residential real estate brokerage business under the Coldwell Banker, Corcoran, and Sotheby's International Realty brand names to assist home buyers and sellers in the listing, marketing, selling, and finding homes.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Oct. 22, 2021
Everything we know about the Trump Media and Technology Group IPO, plus information on how to buy in.
Steps to owning and managing Valkyrie Bitcoin Strategy ETF units.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Oct. 21, 2021
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.